DrugPatentWatch Database Preview
Patent: 7,371,759
Try a free trial
See Plans and Pricing
Summary for Patent: 7,371,759
| Title: | HMG-CoA reductase inhibitors and method |
| Abstract: | Compounds are provided having the following structure which are HMG CoA reductase inhibitors and thus are active in inhibiting cholesterol biosynthesis, modulating blood serum lipids, for example, lowering LDL cholesterol and/or increasing HDL cholesterol, and treating hyperlipidemia, dyslipidemia, hormone replacement therapy, hypercholsterolemia, hypertriglyceridemia and atherosclerosis as well as Alzheimer\'s disease and osteoporosis ##STR00001## wherein X is N or CR.sub.5; and pharmaceutically acceptable salts thereof, ##STR00002## wherein R.sub.1 to R.sub.7 are as defined herein. A method for treating the above diseases employing the above compounds is also provided. |
| Inventor(s): | Ahmad; Saleem (Wall, NJ), Robl; Jeffrey A. (Newtown, PA), Ngu; Khehyong (Pennington, NJ) |
| Assignee: | Bristol-Myers Squibb Company (Princeton, NJ) |
| Application Number: | 10/946,055 |
| Patent Claims: | see list of patent claims |
Details for Patent 7,371,759
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Centocor Inc | REOPRO | abciximab | INJECTABLE; INJECTION | 103575 | 001 | 1994-12-22 | Try a Free Trial | Bristol-Myers Squibb Company (Princeton, NJ) | 2023-09-25 | RX | search | |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 001 | 2015-01-23 | Try a Free Trial | Bristol-Myers Squibb Company (Princeton, NJ) | 2023-09-25 | RX | Orphan | search |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 002 | 2015-01-23 | Try a Free Trial | Bristol-Myers Squibb Company (Princeton, NJ) | 2023-09-25 | RX | Orphan | search |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 003 | 2015-01-23 | Try a Free Trial | Bristol-Myers Squibb Company (Princeton, NJ) | 2023-09-25 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
